Anticancer Plants and Their Conservation Strategies: An Update

Kumar, Vankayalapati Vijaya; Swamy, Mallappa Kumara; Akhtar, Mohd Sayeed

doi:10.1007/978-981-10-8548-2_20

Cited by 5 publications

(1 citation statement)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The WHO estimates that plant-based medicines provide principal healthcare for around 3.5–4 billion citizens globally [ 20 ]. The International Union for Conservation of Nature and World Wildlife Fund estimated that universally, above 50,000 plant species find use in medicinal purposes [ 21 , 22 ]. Around 25% of pharmaceuticals have a direct or indirect plant-based origin [ 23 , 24 ].…”

Section: Introductionmentioning

confidence: 99%

Crosstalk of Multi-Omics Platforms with Plants of Therapeutic Importance

Pandita¹,

Pandita²,

Wani

et al. 2021

Cells

View full text Add to dashboard Cite

From time immemorial, humans have exploited plants as a source of food and medicines. The World Health Organization (WHO) has recorded 21,000 plants with medicinal value out of 300,000 species available worldwide. The promising modern “multi-omics” platforms and tools have been proven as functional platforms able to endow us with comprehensive knowledge of the proteome, genome, transcriptome, and metabolome of medicinal plant systems so as to reveal the novel connected genetic (gene) pathways, proteins, regulator sequences and secondary metabolite (molecule) biosynthetic pathways of various drug and protein molecules from a variety of plants with therapeutic significance. This review paper endeavors to abridge the contemporary advancements in research areas of multi-omics and the information involved in decoding its prospective relevance to the utilization of plants with medicinal value in the present global scenario. The crosstalk of medicinal plants with genomics, transcriptomics, proteomics, and metabolomics approaches will be discussed.

show abstract